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The recent explosion of biotechnology has raised many ethical and religions questions
amongfaith communities. Many ofthesefaith communities are attempting to balance modern
technology and historical religion. Using .xenotransplantation as a case study, the transplan-
tation of genetically engineered animal organs into human beings, this article follows three
major religious traditions through the discernment process of how to dealfaithfully with this
new technology. In addition, the role of the biotechnology industry and the pressures that
researchers face are also explored in the conte.xt of investigating how to effectively integrate
science and religion into future bioethical discussions.
Different religions, and different denomi-
nations within those rehgions, have different
orientations to begin the bioethical discussion
of the issues surrounding biotechnology. The
starting place could be the scriptures specific
to each religion, or it could be pure reason, or
philosophical mandates, or a mixture of the
three. Rarely, however, does this starting
place detemiine the eventual answer of a reli-
gious group to a bioethical question. Groups
that have widely varying theologies (or no
unifying theology at all) often come to the
same conclusion through different paths of
logic. Rather than the specific theology de-
termining the final bioethical decision, it stems
largely from how a religious group defines
life.
In hindsight, this orientation is logical,
since most bioethical decisions involve de-
termining moments at the beginning or end
of life, and the definition life itself. Many of
these decisions also involve identifying the
role of human life in relation to other forms
of life, nonhuman animals and plants. There
is another layer of difficulty in bioethical de-
cisions when the life of one requires the death
of another (such as those involved in organ
transplantation, or when pregnancy threatens
the life of the mother). This is when the defi-
nition of life becomes critical. When does
life begin? When does it end? How is it de-
fined? How is it valued? Doesquality of life
matter, or is it simply life itself that is val-
ued? Where does human life fit within the
schema of all life? Does life exist after death?
Is life special, or only an accidental force of
nature?
As part of this exploration. I examined the
bioethical decision-making process from a
variety of different religious groups on the
issue of xenotransplantation. In cases where
a religious group had not yet developed an
official position, information regarding their
position on the beginning and ending of life,
genetic engineering, animal rights, and other
defining issues was gathered. Xenotransplan-
tation involves the implantation of nonhuman
animal organs (usually pig, due to immuno-
logical similarities, organ size, rapidity of the
growth cycle, and the size of litters) into hu-
man beings, when human donor organs are
unavailable. The issues surrounding this op-
eration are complex. They range from the im-
mediate situation of performing the surgery
itself, to future considerations such as pos-
sible transfer of disease from one species to
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another, and the rights of the donor animals,
raised in a sterile environment and genetically
engineered to ensure a more successful trans-
plant procedure.'
While I could continue at length regard-
ing the specific issues surrounding xenotrans-
plantation, the purpose of this paper is to ex-
amine the various pressures on the decision-
makers of some major religious groups in the
United States that draw them toward a spe-
cific bioethical conclusion. Since "'transplan-
tation reveals cultural values that we assign
to our bodies and challenges assumptions con-
cerning the body and personal identity,"" the
topic of xenotransplantation could have a deep
impact in the discussion venues of religious
communities that perceive the self as sacred
and human beings as separate from other ani-
mals.'
This preliminary study is limited to those
groups that have a large population in the
United States and use diverse methodologies
for determining the bioethical decisions for
their religious communities. Three of these
religiously oriented bioethical discussions are
summarized below: United Methodist, Con-
servative Jewish and Sunni Muslim.
In addition, 1 explore how biotechnology
industry groups make bioethical decisions. It
is important to understand the thought pro-
cesses of those in the laboratory situations
who create the technologies and procedures
that must later be debated.
Sunni Islam
The Islamic tradition has an outstanding
history with medicine. From the founding of
the first formal medical schools to the great
"Prince of Physicians," Avicenna (Abu Ali at-
Husain ibn Abdullah ibn Sina) of the Middle
Ages, the great Islamic kingdoms of the
Middle East maintained the traditions of learn-
ing and medical education throughout the time
when Europe was plunged into the Diuk Ages.
While their religious books prevented the Is-
lamic doctors of this era from performing au-
topsies or examining too closely the niiked
form of female patients, the Islamic medical
tradition took giant leaps in performing some
of the first phamiacological and wound care
studies. "*
Modern Islam, like many modern reli-
gions, struggles in the tension between con-
temporary knowledge and ancient teachings.
However, when the two come into conflict,
usually the ancient teachings are given pre-
cedent over the contemporary knowledge.
Islamic faith holds that the human being is
the perfect creation of Allah .^ Human beings
must be honored as human beings; to do oth-
erwise is to insult God. Humans are set both
apart from and above the other animals.
Therefore, in reference to the xenotransplan-
tation discussion, to utilize any part of an ani-
mal to save a human would decrease the re-
sulting value of that human.' Rather than
being entirely human as God's inviolate cre-
ation, the person would be partly human and
partly nonhuman; part higher being and part
lower organism. Doctors should allow the in-
dividual to die with dignity rather than per-
form a zenotransplantation that would confer
the humiliation of living in some partial-hu-
man state. Not only would there be religious
repercussions for the patient of a xenotrans-
plantation operation, but any doctor perform-
ing that surgery would be destroying God's
creation and would be called by God to ac-
count for that destruction.
This position statement expands beyond
the surgery itself, since prior to implement-
ing this type of surgery, experimentation must
be performed. This is forbidden.^ To violate
a human being or human tissue through ex-
perimentation in xenotransplantation is pro-
hibited since it would ultimately decrease the
value of human life. The possibility of sav-
ing lives tlirough xenotransplantation is not
the primary consideration, since death comes
to everyone as a member of God's creation.
Dying allows the individual to return to Al-
lah; it is not a tragedy. Rather, it is a gift from
Allah as a reward for a good life.^ To per-
form extreme measures that violate the hu-
man body, such as xenotransplantation, is to
deny Allah's gift and to make a demand for
more of this life and a spurning of the next.
Death is a part of life. While medical research
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should enhance the hfe we are given, it should
not run counter to the natural state of life and
death.*
Conservative Judaism
Judaism has a long history with medicine.
The tradition's earliest holy writings include
many commandments that logically contrib-
uted to health and well-being in an otherwise
The topic ofxenotransplantation could
have a deep impact in the discussion ven-
ues of religious communities that perceive
the self as sacred and human beings as
separate from other animals.
uncertain time. Ritual hand-washing, rapid
disposal of the dead, and sanitation rules all
served to decrease the level of illness and dis-
ease in eaily Jewish society compared to other
groups of that era.^ In conjunction with their
historical position against mutilation of the
dead, many Constrvative Jewish families to-
day still choose to circumvent autopsy and
embalming the dead. This injunction against
autopsy did hinder some aspects of historical
Judaic medicine, since there was a resulting
lack of understanding regarding the internal
organs and systems of the body. However,
Jewish medical practices remained far ahead
of other cultures in the field of preventive
medicine until the discovery of germ theory
allowed the Western world to catch up with
many of the practices the Jewish community
had begun thousands of years earlier.
In Judaism, theology is completely inter-
twined in medicine. Only God is acknowl-
edged as rofe, t)r "healer." While this larger
concept may be unfamiliar, many non-Jews
may recognize the name of the angel Raphel
—
Rofe-EI, or "the healing of God"—as a con-
venient reference point for this idea. Jewish
doctors merely assist in God's healing touch.
Only God can create life, and only God has
the right to take life away. In context, this
means that if God provides the means to save
a life, then that life must be saved, regardless
of whether it breiiks a religious commandment.
In Jewish medicine, human life must be pre-
served at all costs. Therefore, when bioethi-
cal decisions must be made that would other-
wise jeopardize a specific religious law, the
decision is always made in favor of life.'"
Since the Torah obviously does not have
any specific commandments regarding xeno-
transplantation, religious scholars look instead
at stories where religious
laws were broken under
the greater command-
ment to preserve life.
One such passage is the
story of David who broke
into a religious site and
ll ate the bread that was re-
served solely for the
priests. God allowed this action, even though
it had been previously forbidden in the reli-
gious laws, since the bread kept David and
his companions from starving to death. Many
Jewish scholars apply that story to the cur-
rent biotechnology discussions, including that
of xenotransplantation. In xenotransplanta-
tion, animal organs (usually from a pig) are
implanted into a human recipient to save the
life of a human being. Though kosher laws
would prevent the taking of pig tJesh into the
body (the injunction against eating pork),
these dietary laws would not take a higher pre-
cedence than saving a human life."
Since preserving human life takes prece-
dence over all other considerations and su-
persedes all other religious laws, Jewish medi-
cal theology has a perspective different from
that of Sunni Islam.'- Therefore, while there
remains a great deal of discussion in the Jew-
ish community surrounding various biotech-
nological advances, particularly in the areas
of interfering with God's creation and the bio-
ethics of performing the research itself, there
is also a relatively positive reception in those
areas that could lead to saving lives.
United Methodist Church
Historically, Christianity has had a suspi-
cious relationship with science and medicine.
Stories of healing by faith can be found in the
earliest Christian holy writings. By the
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Middle Ages, a popular theology had devel-
oped around sickness and health. It was be-
lieved that God meted out illness as a fonn
of punishment for sins. Only God should
perfomi healing, though humans could pre-
cipitate this healing by making pilgrimages
and seeking out holy relics. During the same
era that Islam was making great strides in
science and medicine. Christian Europe
closed in on itself, often torturing or killing
those who attempted to integrate new tech-
niques or knowledge into medicine. In fact,
during that era the Church threatened excom-
munication to any Christian that studied at
an Islamic medical school. While doctors
and surgeons (considered much less presti-
gious than doctors because they manipulated
the body, while doctors dealt solely with
pharmaceuticals) did practice during this pe-
riod, training occurred through apprentice-
ship, and most of the medicine practiced was
ineffective at best, and lethal at worst.
Over time, this attitude has undergone a
significant alteration, particularly in the lib-
eral Protestant denominations, such as the
United Methodist Church (UMC). While
remnants of religious suspicion of science can
still be found among some Christian groups,
many denominations are embracing, or at
least considering, most modern medical tech-
niques. Medical study is supported; autopsy.
Since preserving human life takes prece-
dence over all other considerations and
supersedes all other religious laws, Jewish
medical theology has a perspective differ-
entfrom that ofSunni Islam.
surgery, and medical treatment are no longer
discouraged. However, with modern ad-
vances that could result in an alteration of the
genome and with some forms of medical re-
search, new caution has been raised as to the
bioethics surrounding some of these medical
procedures.
In order to identify and address these
biotechnical issues that may have important
ethical considerations, the United Method-
ist Church created The Genetic Science Task
Force within the larger committee. Ministry
of God's Creation. The larger committee is
designed to deal with general biological is-
sues such as ecological stewardship. The
Genetic Science Task Force's original role
within that group was to specifically discuss
medical techniques dealing with genetic en-
gineering, and research in those areas. Over
time the role of the Task Force has expanded
to include other areas of medical bioethics
as well and committee members now include
research biologists, medical doctors, and
laboratory specialists in addition to theolo-
gians. This organization presents its re-
search, deliberations, and conclusions to the
larger church body. However since the
United Methodist Church has a centralized
structure, no sub-body of the church has the
ability to speak for the church as a whole.
Consequently, the Task Force is quick to
point out that they do not speak for the
United Methodist Church and their findings
do not become church policy unless ratified
by the Quadrennial All-Church Confer-
ence."
The Task Force has not explored the spe-
cific area of xenotransplantation yet. How-
ever, their previous
deliberations that
have been ratified by
the entire United
Methodist Church in-
clude position state-
ments on the topics of
cloning and genetic
engineering, which
'^ can be found in the
"^ Book of Discipline of
the United Methodist Church in the section
entitled "Social Principles: The social com-
munity: Genetic technology." The Task
Force has created resolutions against the pat-
enting of life in any form. Therefore, claim-
ing that specific plants, animals, bacteria, or
even genetic sequences "belong" to any per-
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son or company is contrary both to the pur-
pose of good science and to proper steward-
ship of God's creation.'"* The UMC has also
released statements that, while they fully sup-
port the use of genetic engineering to eradi-
cate genetic disease or disability, still decry
the use of genetic engineering for cosmetic,
or socio-economic purposes. Expanding on
their genetic engineering position, they state
that while they approve somatic genetic al-
terations (those that affect only the individu-
als who receive the treatment), they stand
firmly against genetic alterations to the germ
line (resulting in changes to the sperm or egg
cells that could be passed down to the next
generation). The United Methodist Church
also spoke out against research into any thera-
pies, such as those working with early stage
genetic alterations, that knowingly waste hu-
man embryos.''' Interestingly, there is cur-
rently no language in their policies regarding
the use of fetal tissue, since no agreement has
yet been reached on the issue."'
As one of the largest organized Protestant
denominations in the United States, the UMC
is often placed between some members' de-
sire unabashedly to encourage modern tech-
nology and its development and the more con-
servative counterparts that strongly advise
caution surrounding the bioethical issues in-
volved in these new technologies. In an at-
tempt to ensure that all the voices be respect-
fully heard, the UMC does not speak on areas
where consensus has not been reached. The
Task Force acts only on full consensus. On
those topics where consensus cannot be
reached, the Task Force, and consequently the
United Methodist Church, is intentionally si-
lent.''' Therefore, since they have not yet ex-
plored the topic, the UMC maintains no offi-
cial position, theologically or ethically on
xenotransplantation or on any of the surround-
ing issues involved, though the church's po-
sition on genetic engineering may provide
preliminary insight into the Task Force's bio-
ethical deliberations. After the Quadrennial
All-Church Conference in 2000, the Task
Force renewed discussion on contemporary
bioethical issues.
Biotechnology laboratories
For the scientists at the leading edge of
this field and in the laboratories, there are
multiple concerns, very few of them of a bio-
ethical nature. There are strong economic
pressures at work among small biotechnol-
ogy companies.'** The companies require ex-
pensive equipment and materials that usually
are financed by investors (either private or on
the public stock markets). Start-up costs alone
can easily reach the multi-millions of dollars.
These investors expect a return for their fi-
nancial input relatively quickly. Conse-
quently, these companies feel the pressure to
produce and patent their products as soon as
possible, so that they can be placed on the
market and the investors can begin to reap the
benefits from acquiring a piece of the com-
pany. Biotechnology companies rise and fall
almost on a daily basis; it is a difficult fight
just to stay alive in a bmtal market. There-
fore, it is usually economic pressures, not bio-
ethical ones, which determine the research
agenda for a company.'**
Even if economic pressures are not se-
vere, bioethical issues still do not take the
top priority in industrial biotechnology. Af-
ter economics pressures are eased, the thrill
of pure research is the next enticement to
take effect. Interviews with a variety of bio-
technology scientists suggest that it is the
love of exploration that initially drew them
into the field.-"'' ---' In fact, many of the
younger scientists lament upward career
movement that usually means less time in
the lab and increased time with paper and
administrative work. As one young woman
mentioned. "'If I do a good job doing what I
love in the lab, they take me out of the lab
and make me do work I hate. What incen-
tive!"'^
In most cases the biotechnicians are the
best equipped both to understand the sciences
involved, as well as to speculate on potential
harmful outcomes. Yet, due to their fomial
scientific training requirements, the research-
ers are possibly the most poorly equipped to
understand or predict the bioethical issues sur-
rounding those outcomes. In general, scien-
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tific researchers do not have an educational
background in ethics needed to formulate
these issues for discussion, and they often
consider instigating the discussions as one
more form of administrative work that would
pull them away from their labs.-^ Therefore
the discussions, when they occur, will occur
less often with the young scientists, who are
actually in the laboratories performing the
work, and more often with the upper level ad-
nations. Since small family farms depend
on seeds held back from the previous year's
crop to replant the following year, this type
of seed would lead to a famine after a single
growing season. The second point of attack
stemmed from biologists concerned about
cross-pollination altering the genome of
regular crops, making them sterile for the
next planting season. Outrages over these
possibilities forced Monsanto to back-step
« and remove their termi-
In general, scientific researchers do not | nation seed from the
have the educational background in eth- I '^'^'''" ^""^^"^« '° ^^" bdlions or dollars m re-
ics needed to formulate these issues for search and develop
discussion, and they often consider insti- I "^'^"^' ^^ ^^" ^^ ^ """^"
. ber ot their customers,
gating the discussions as one moreform over the issue, how-
of administrative work that would pull ever, it forced the bio
technology industry tothem awayfrom their labs.
ministration, some of whom have not spent
any serious laboratory "bench time" in over
ten years.
The field, however, is beginning to un-
derstand the financial value of assessing the
bioethical issues prior to moving toward a
goal.-'' The industry pays particular atten-
tion when the bioethical issues begin to im-
pact their national or international economic
interests.'^ Consider the recent example of
the need for biotechnology companies to re-
search the bioethical issues before beginning
a multi-million-dollar process of developing
a new product line: the upheaval in the
Monsanto Company when public backlash
forced them to remove their new second-gen-
eration termination seed from the market.
The Monsanto Company created seed that
does not have a second-generation germina-
tion cycle; that is, seed gathered from the
original crop is sterile. Thus, the fanner is
forced to buy new seed every year from the
company.'** Bioethicists consequently at-
tacked Monsanto on two points. The first
was Monsanto's proposed "humanitarian ef-
fort'Vtax write-off, the donation of tons of
this type of seed to fanners in developing
g take an interest in the
fc bioethics of their re-
search. In addition, it provided evidence that
grass-roots bioethical movements can make
a significant impact and alter the position of
major international companies.
Science and religion working
together
As evidenced by the three religious per-
spectives and contrasted with the values of
the biotechnology industry, it is obvious that
the area of religious bioethics is complex, and
many questions need to be answered prior to
proceeding with the use of xenotransplanta-
tion. Each of the religious groups has care-
fully considered its position on bioethical is-
sues, and each has a history and tradition to
support its current position. Yet, these posi-
tions are certainly very different. On the is-
sue of xenotransplantation alone these three
groups state positions of "absolutely yes,"
"maybe," and "absolutely no." How can all
of the voices in this country be heiird and in-
tegrated into policy decisions, particularly
when they are so disparate? And when deci-
sions are made, what are the rights of the mi-
nority in that decision-making process? While
medical capabilities continue to race ahead.
322 The Journal ofFaith and Science Exchange, 2000
there are still issues to be solved prior to their
implementation.
There is one major question that ethicists
and theologians must be able to answer to en-
sure a future for ethically considerate scientists.
How can ethics be integrated into a standard
scientific course of study? And further, how
can science literacy be integrated into theologi-
cal and ethical courses of study? As one of the
individuals who straddle these two worlds, I
can certainly see the value in creating the "re-
naissance researcher," an individual who un-
derstands both what he or she is creating and
the implications of creating it. Humankind has
long ago left the "age of innocence," where they
can idyllically believe that science and scien-
tists are "pure," and that only those who imple-
ment the science must worry about messy bio-
ethical issues. The creators, too, need to un-
derstand the implications of what they are cre-
ating. However, as the situation currently
stands, my undergraduate science degree makes
me rather unusual in theological discussions,
and my theological training makes me very
unique in most scientific settings. Further, my
scientist friends look at me askance when I
begin discussing the ethical issues surround-
ing the science involved in a project, and my
theology friends are equally discomforted when
I begin to talk about the realm of science.
It may be that neither field equips its stu-
dents to function in the world of the other.
Each person has specific aptitudes and inter-
ests. It is rather uncommon to find an indi-
vidual that has both the time and inclination
to become fluent in both the realms of sci-
ence and ethics/theology/philosophy. Further,
the professors from those fields would pur-
port that there is not even sufficient time in
the current degree programs to get through
the necessary preparatory curriculum, much
less attempting to add a class outside of the
field into an already full schedule. ""' Until cur-
riculum committees of these departments are
convinced of the value of cross-educating their
students, it will remain a difficult fight to have
these classes included in the curriculum.
This is not to say that all hope is lost, how-
ever, in attempting to create areas of commu-
nication between the two fields. A renewed
(or completely new. in many instances) inter-
est in bioethics caused the recent biotechnol-
ogy conference, hosted by Biotechnology In-
dustry Organization (BIO) in Boston, to draft
a set of bioethical principles by which to di-
rect the future of their research.'" Within the
preamble to these principles, one can sense a
major change in the attitude the biotechnol-
ogy industry toward bioethics.
While biotechnology can greatly
improve the quality of life, we
recognize that this new technology
should be approached with an appropri-
ate mixture of enthusiasm, caution and
humility. Biotechnology can provide
useful tools for combating disease,
hunger and environmental contamina-
tion, but it should not be viewed as a
panacea or as miraculous. For example,
life-saving medicines may have serious
side effects, and, while our expanding
knowledge of genetics can help create
the next generation of medicines, it can
also raise important ethical issues."
While this statement may be taken with
at least a partial sense of irony, since a repre-
sentative of the protesters outside the Biotech-
nology Conference was not allowed to speak
inside the meeting hall, the statement at least
represents a beginning to opening the discus-
sii)n with ethicists, theologians and govern-
ment officials. Additionally, the newly de-
veloped biotechnologies with worldwide im-
plications have peaked theology's interest
in science as well.
In addition to biotechnology beginning to
open its doors, theologians are beginning to
recognize the role that they must play in these
decisions as well, and that this role must be a
central one on the world stage, rather than sim-
ply commentiuy from the behind the curtains.
The creation of programs such as the Science
and Religion Certificate at the Boston Theo-
logical Institute and the doctoral program in
Philosophy, Science, and Religion at Boston
University shows that there is a movement
afoot to train theologians and scientists to
range widely across both fields and to be able
to influence developments in both. While this,
of course, is not the final solution, it certainly
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is a strong beginning. By increasing theolo-
gians' scientific literacy, there will be more
opportunities for those theologians to take a
meaningful role in future bioethical decisions
made at the political, economic, and religious
levels
While the door may now be opened, ethi-
cists should not forget the economic pressures
that initially opened the discussions.^- Un-
fortunately, industry in a capitalist society can
be fickle. Should the bioethical discussion
ever become sufficiently costly in the
industry's cost-benefit analysis, the talks will
probably close again. That places the bioet-
hicists in a position of needing to continue
the economic pressure on the biotechnology
companies. The discussion is beginning, but
a vision of what biotechnology can accom-
plish has only been glimpsed. It is impera-
tive that those who live "dual lives" in the
worlds of science and religion continue the
discussions.
Concerned ethicists and scientists need to
continue the pressure on biotechnology com-
panies, but it cannot stop there. Opening and
maintaining the discussion will require a co-
operative effort across multiple areas of sci-
ence and religion. However, in order for the
fields to make headway in fruitful discussion,
there will be a need for individuals who are
tluent in the languages of both areas to act as
mediators among the different groups at the
table. The first step in creating those media-
tors begins with educating young scientists
in the ethics of their field, and integrating sci-
ence into a theological curriculum. Only then
can discussions continue on equal footing with
all parties coming to the table with the bioet-
hical interests of the global community in
mind.
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